Scholarlink

<p><sup>225</sup>Ac targeted alpha therapy is characterized by high linear energy transfer (LET) and short range, which has demonstrated outstanding therapeutic effects and minimal adverse effects in the treatment of prostate cancer and neuroendocrine tumor. This review paper aims to summarize the research conducted to date on <sup>225</sup>Ac targeted alpha therapy applied to the treatment of patients with prostate cancer and neuroendocrine tumor. Efforts has been made to improve the therapeutic outcomes of <sup>225</sup>Ac targeted alpha therapy by exploring new protocols, and its application has been expanded to treat other types of tumors beyond these disease entities. Although numerous studies have reported the excellent therapeutic effects of <sup>225</sup>Ac targeted alpha therapy, further clinical research is required for it to become established as a standard clinical treatment.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Clinical perspective on targeted alpha therapy using 225Ac

  • 期刊论文

  • 发表日期：

    2025年10月9日

查看全文
  • Ilhan Lim

摘要

225Ac targeted alpha therapy is characterized by high linear energy transfer (LET) and short range, which has demonstrated outstanding therapeutic effects and minimal adverse effects in the treatment of prostate cancer and neuroendocrine tumor. This review paper aims to summarize the research conducted to date on 225Ac targeted alpha therapy applied to the treatment of patients with prostate cancer and neuroendocrine tumor. Efforts has been made to improve the therapeutic outcomes of 225Ac targeted alpha therapy by exploring new protocols, and its application has been expanded to treat other types of tumors beyond these disease entities. Although numerous studies have reported the excellent therapeutic effects of 225Ac targeted alpha therapy, further clinical research is required for it to become established as a standard clinical treatment.